TABLE 1.
Primers used in this study.
| Gene | Primer | Sequence |
|---|---|---|
| Human MALAT1 | Forward | 5′- GTCATAACCAGCCTGGCAGT -3′ |
| Reverse | 5′- CGAAACATTGGCACACAGCA-3′ | |
| Murine MALAT1 | Forward | 5′- TGCAGTGTGCCAATGTTTCG -3′ |
| Reverse | 5′- GGCCAGCTGCAAACATTCAA -3′ | |
| Human DLL1 | Forward | 5′- GTTTCCCGAGGTTGCCTTTCC -3′ |
| Reverse | 5′- CTCTCCTTAGAACAGCGGCG-3′ | |
| Murine DLL1 | Forward | 5′- TGATCGTGGACAACACGGAG -3′ |
| Reverse | 5′- TCGTCTGGCTTTCAGTCCAC-3′ | |
| Human β-actin | Forward | 5′- CATTCCAAATATGAGATGCGTTGT -3′ |
| Reverse | 5′- TGTGGACTTGGGAGAGGACT -3′ | |
| Murine β-actin | Forward | 5′- GGCTGTATTCCCCTCCATCG -3′ |
| Reverse | 5′- CCAGTTGGTAACAATGCCATGT -3′ | |
| Human U6 | Forward | 5′- CTCGCTTCGGCAGCACA-3′ |
| Reverse | 5′- AACGCTTCACGAATTTGCGT-3′ | |
| Murine U6 | Forward | 5′- ACGGCTACCTCTCAATCCCA-3′ |
| Reverse | 5′- GATGCCCGTTGTAGGTCTCC-3′ | |
| Human miR-449a | Forward | 5′- GTGCTGTGGCAGTGTATTGTTA-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACCAGC-3′ | |
| Human miR-25-3p | Forward | 5′- GCCATTGCACTTGTCTCG-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTCAGAC-3′ | |
| Human miR-34a-5p | Forward | 5′- GTGCTGGCAGTGTCTTAGC-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAACC-3′ | |
| Human miR-429 | Forward | 5′- GCGGTCTAATACTGTCTGGTAAAAC-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACGGTTT-3′ | |
| Human miR-92a-3p | Forward | 5′- GTCTATTGCACTTGTCCCGG-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAGGC-3′ | |
| Human miR-32-5p | Forward | 5′- GCGGTGTATTGCACATTACTAAG-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTGCAAC-3′ | |
| Human miR-92b-3p | Forward | 5′- GTTATTGCACTCGTCCCGG-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGGAGGC-3′ | |
| Human miR-363-3p | Forward | 5′- GCGAGCAATTGCACGGTATCCAT-3′ |
| RT | 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTACAGA-3′ |